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Long-term outcomes and resource utilization of
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Carl van Walraven, MD, MSc, FRCP,b,c Ottawa, Ontario, Canada
Objective: Two large randomized trials showed that elective endovascular aneurysm repair (EVAR) had similar all-cause
long-term mortality rates but increased costs compared with open repair for nonruptured abdominal aortic aneurysms
(AAAs). Despite these data, the use of EVAR continues to increase in North America. Currently, there are very limited
adjusted population-based data examining long-term outcomes and resource utilization.
Methods: All patients who underwent elective AAA repair between April 2002 andMarch 2007 in Ontario were identified
using data from hospital discharge abstracts. Patients were identified with a validated algorithm. A propensity score
analysis was used to adjust for treatment allocation. Clinical outcomes included time to all-cause death and discharge to
a nursing home or long-term care facility. Resource utilization outcomes included imaging utilization, hospital
utilization, and reintervention rates.
Results: Overall, 6461 patients underwent treatment of nonruptured AAAs, comprising 888 EVARs and 5573 open
repairs. EVAR patients were older and had more comorbidities. The adjusted mortality was significantly lower in the
EVAR group at 30 days (adjusted odds ratio [adj-OR], 0.34; 95% confidence interval [95% CI], 0.20-0.59), but
long-term mortality was similar (adj-OR, 0.95; 95% CI, 0.81-1.05). EVAR patients were significantly less likely to be
discharged to a nursing home or other chronic care facility (adj-OR, 0.55; 95%CI, 0.41-0.74). Imaging utilization as well
as urgent and vascular readmissions were significantly higher in the EVAR group. However, the EVAR group had a
significantly shorter length of stay and less intensive care unit use for the index hospitalization and decreased hospital
length of stay during follow-up. There was a trend toward a slightly increased risk of reintervention with EVAR (adj-OR,
1.3; 95% CI, 0.98-1.75).
Conclusion:Compared with open repair, EVAR significantly reduced short-term but not long-termmortality. The EVAR
patients spent less time in health institutions, including long-term care facilities, but underwent more imaging studies.
Future improvements in EVAR could result in further decreases in reinterventions and subsequent radiologic monitor-
ing. (J Vasc Surg 2010;51:577-83.)Since it was introduced in 1991,1 endovascular aneu-
rysm repair (EVAR) has seen a constant evolution in de-
vices and expertise and is presently challenging open aneu-
rysmorrhaphy as a less-invasive standard of care for the
elective treatment of abdominal aortic aneurysms (AAAs).
Popularity for this less-invasive method has grown, and
traditional restrictions to a high-risk population are no
longer apparent, leading to rapid and wide-scale implemen-
tation.2 Systematic reviews of nonrandomized trials and
two randomized controlled trials of low-risk patients have
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doi:10.1016/j.jvs.2009.10.101confirmed that EVAR is associated with significant reduc-
tions in operative mortality, intraoperative blood loss, and
hospital length of stay.3-5
However, enthusiasm for EVAR has been tempered by
a better understanding of its long-term durability. In-
creased reintervention rates, as high as 35% at 3 years, were
originally reported in long-term follow-up studies and ne-
cessitated regular postoperative surveillance with imaging
studies.6-8 More importantly, data on the effect of EVAR
on long-term protection from subsequent AAA rupture
and death has been limited and inconsistent.9-16 Midterm
results from two randomized controlled trials demon-
strated that the initial operative survival advantage after
EVARwas not sustained with respect to all-cause mortality,
with EVAR having a higher associated reintervention rate
and cost.17,18 Certain reservations about the conclusions of
the randomized trials were presented and EVAR use con-
tinued to increase.19
Limited, generalizable population-based data are avail-
able to compare long-term outcomes of EVAR with open
AAA repair. A recent large American population-based
review of Medicare A and B beneficiaries 67 years of age
demonstrated an initial survival advantage for up to 3 years
in patients undergoing EVAR but with an increase in
AAA-related reinterventions.20 This was the first and only
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sults of EVAR and open repair. Our study further deter-
mined the validity of these results in a broader patient
population that included all age groups in a universal health
care system. With rapidly evolving technology and liberal-
ization of EVAR to younger and lower-risk patients, it is
important that current information is gathered to further
inform patients and physicians of the long-term durability
and health care resource utilization of EVAR.
This study compared population-based clinical out-
comes and resource utilization for EVAR and open repair
of all elective AAA repairs in Ontario, Canada, between
2002 and 2007.
METHODS
Study overview. This retrospective cohort study used
administrative databases of all patients who underwent
surgical repair of a nonruptured AAA in Ontario between
April 1, 2002, and March 31, 2007. All interventions were
by a conventional open repair or by EVAR.
All study data were obtained from several population-
based administrative databases. The primary database was
the Canadian Institute for Health Information-Discharge
Abstract Database (CIHI-DAD), which contains informa-
tion on all acute care and day surgery institutions in On-
tario. Each observation (or row) in the database represents
one admission and contains patient demographic informa-
tion (including gender and date of birth), admission infor-
mation (including admission urgency, admission and dis-
charge dates, and disposition), and clinical information
(including up to 25 diagnoses and 25 procedures). Diag-
noses are coded using the International Statistical Classi-
fication of Diseases and Related Health Problems, 10th Re-
vision (ICD-10), and procedures are coded using the
Canadian Classification of Health Interventions (CCI),
unlike in the United States, which used ICD-9 for both
diagnostic and procedural coding during the study period.
Other databases used for the study included the On-
tario Diabetes Database (which captures patients with
treated diabetes), the Registered Persons Database (which
captures the death dates of all Ontarians), the Ontario
Myocardial Infarction Database (which captures all myo-
cardial infarctions and coronary revascularizations), the
OntarioHealth Insurance Plan database (which captures all
physician visits and imaging studies), and the Ontario Drug
Benefits Database (which captures all prescriptions for pa-
tients exceeding 65 years or those on social assistance).
These databases were linked by a patient identifier number
that was common to each database.
Inclusion and exclusion criteria. Ontario patients
were included in the study if they underwent operative
repair of a nonruptured AAA by open surgical technique or
by EVAR. Excluded were patients with ruptured aneu-
rysms, thoracic aneurysms, isolated iliac aneurysms, and
pseudoaneurysms. Non-Ontarians who underwent surgical
repair in an Ontario hospital were excluded because their
follow-up period is not captured by the Ontario health
databases used for the study.All patients were identified and classified using a vali-
dated algorithm of ICD-10 diagnostic codes and CCI
therapeutic codes developed by our team (Appendix I,
online only).21 Patients were classified in the open surgical
group if they were coded with a diagnosis of nonruptured
AAA and had an intervention code for an open AAA
procedure. Patients were placed in the EVAR group if they
were coded with a diagnosis of nonruptured AAA and
intervention codes for an EVAR. All duplicate patient
admissions were identified, and only the first admission was
kept to ensure that a particular patient appeared only once
in the study.
Study outcomes. The primary outcome was time to
all-cause death after AAA repair, calculated as the number
of days between the index operation, and death from any
cause. Because of legal reporting requirements, registration
of deaths inOntario is virtually 100% complete. Death from
any cause 30 days of the index operation was defined as
30-day mortality.
The secondary outcomes measured to reflect resource
utilization were total length of stay and intensive care unit
(ICU) length of stay during the index hospitalization;
discharge to a nursing home or long-term care facility;
number of imaging studies, including abdominal com-
puted tomography scans, magnetic resonance imaging, or
angiograms per patient-year; number of outpatient doctor
visits to a general practitioner or a specialist per patient-
year; number of urgent and vascular readmissions per
patient-year; and days in-hospital per patient-year, which
includes the index hospitalization and all subsequent read-
missions. Reinterventions per patient-year included any
procedure that was potentially related to the AAA repair
(Appendix II, online only). In addition to vascular, endo-
vascular, and interventional procedures, this included ab-
dominal wall procedures such as dehiscence and hernia
repairs.
Controlling variables. We controlled for chronic co-
morbidities using the Charlson Comorbidity Index22 de-
rived using a validated algorithm of ICD-10 codes.23,24
This was supplemented by classifying patients with hyper-
tension, previous laparotomy, the number of medication
prescriptions in the year prior, and the number of urgent
hospital admissions in the prior year (Appendix III, online
only).
Statistical analysis. Baseline covariates were com-
pared using 2 for categoric variables and t tests for contin-
uous variables. Unadjusted survival estimates were calcu-
lated by the Kaplan-Meier method and compared using the
log-rank test. Cox proportional hazard modeling was used
for the adjusted survival analysis. Propensity score model-
ing was used to account for selection bias due to preoper-
ative risk status. The propensity score is the patient’s prob-
ability of treatment assignment (ie, EVAR vs open repair)
conditional on other covariates. The propensity analysis
permitted patients with similar probabilities of receiving
either EVAR vs open repair to be compared. This method
also allowed for analyses between various quintiles and
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fashion compared with traditional regression methods.25
Propensity scores were calculated using multivariable
logistic regression with preoperative patient factors as the
predictor variables and the assignment to EVAR as the
outcome variable. Clinically important interaction terms
were included in themodel (Appendix IV, online only) that
generated the probability that a patient would receive
EVAR vs open repair. Patients were classified into quintiles
by their propensity score. We evaluated the quality of the
model by confirming balance of covariates within each
quintile. Cox models were estimated using the propensity
quintiles as stratifying variables in PROC PHREG using
StatView 9.1 software (SAS Institute, Cary NC). The anal-
yses of incident density rates for resource utilization were
performed using Poisson regression with the addition of
the propensity score as an independent variable using
PROC GENMOD. Statistical values at P  .05 were con-
sidered significant.
RESULTS
Between April 2002 and March 2007, 6461 people
underwent AAA repair in Ontario, of which 5573 had open
repair and 888 had EVAR. Fig 1 presents the total number
of procedures by year. The proportion of all elective AAA
repairs by EVAR increased from 5% in 2002 to 26% in
2007.
Patient characteristics are compared in Table I. The
EVAR patients were significantly older and were more
likely to have significant comorbidities, including heart
disease, hypertension, peripheral vascular disease, cerebro-
vascular disease, pulmonary disease, and diabetes mellitus.
Univariate analysis. The 30-day postoperative mor-
tality was 1.8% after EVAR and 3.4% after open AAA repair
(relative risk, 0.53; 95% confidence interval, 0.31-0.89).
Unadjusted patient survival is presented in Fig 2. An early
Fig 1. Total number of elective endovascular aneurysm repairs
(EVARs, blue) and open aortic aneurysm repairs (AAA; red) by
fiscal year are shown for Ontario between April 2002 and March
2007 (horizontal axis, fiscal year of study; vertical axis, total
elective AAA).survival benefit was documented for patients undergoingEVAR within the first 100 days of observation. Subse-
quently, however, patients undergoing open AAA repair
had significantly better survival (log-rank test P  .0001).
During the index hospitalization, EVAR patients had
significantly shorter hospitalizations and shorter intensive
care unit lengths of stay. After the index hospitalization,
EVAR patients had higher rates for vascular reinterven-
tions, outpatient doctor visits, imaging studies, and hospi-
tal readmissions (Table II).
Multivariate analysis. Table III summarizes all-cause
mortality for EVAR and open repair after adjusting for
baseline risk factors. The Cox proportional hazard analysis
confirmed the significant reduction in 30-day death risk
with EVAR (adjusted hazard ratio [adj-HR], 0.34; 95% CI,
0.20-0.59). Although the univariate analysis demonstrated
a significant decrease in long-term survival among the
EVAR patients (Fig 2), there was no significant difference
in long-term survival after adjustment for baseline risk
factors (adj-HR, 0.95; 95% CI, 0.81-1.05).
After adjustment for risk factors, patients undergoing
EVAR had a significantly shorter length of stay during the
index hospitalization, with an adjusted decrease of more
than half a week compared with open repair (Table IV).
The EVAR patients also had a significantly reduced time in
the ICU of 2.0 days (95% CI, 3.0 to 1.0) and were
significantly less likely to be discharged from the index
hospitalization to a long-term care facility (adjusted odds
ratio, 0.55; 95% CI, 0.41-0.74).
After discharge, EVAR patients underwent more than
five times as many imaging studies than open repair patients
(adjusted rate ratio [adj-RR], 5.5; 95% CI, 4.9-6.1; Table
V). They also had a slightly higher number of outpatient
physician visits (adj-RR, 1.1; 95% CI, 1.0-1.2) and more
urgent or vascular readmissions (adj-RR, 1.6; 95% CI,
1.0-2.4). There was a trend toward more reinterventions in
EVAR patients, but they spent significantly fewer days in
the hospital during the entire follow-up period (adj-RR,
0.67; 95% CI, 0.61-0.74).
Table VI presents the survival analyses by propensity
score quintile. Long-term adjusted all-cause mortality did
not significantly differ between EVAR and open repair in
any propensity score quintile, and there was no identifiable
trend in the hazard ratio across the quintiles. In contrast,
this analysis showed that the benefit of EVAR on 30-day
mortality was prominent and significant for patients whose
risk of EVAR was in the two quintiles with the greatest
probability of receiving EVAR.
DISCUSSION
We studied all patients undergoing repair of nonrup-
tured infrarenal AAAs in the province of Ontario during a
5-year period. After accounting for important comorbidi-
ties, EVAR patients had a lower 30-day mortality, a shorter
ICU stay, a shorter hospitalization, and a decreased risk of
being discharged to a long-term care facility compared with
those undergoing open repair. EVAR did not improve
long-term survival, however, and these patients had signif-
icantly more radiologic tests and hospital readmissions.
ropo
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reductions in operative mortality in EVAR vs open repair of
nonruptured AAA.26-30 The only other population-based
study that compared long-term outcomes of EVAR and open
repair of AAAby Schermerhorn et al20 showed similar survival
benefit in EVAR and open repair patients; however, the sur-
vival curves did not converge until after 3 years. This very large
Table I. Comparison of patients undergoing elective open
aneurysm repair (EVAR) between April 2002 and March 2
Factor
EVAR, %
(n  888)
Median age 76.0 (70.0-81.
Male gender 86.2
Peripheral vascular disease 49.1
Cerebrovascular disease 13.7
Heart disease 42.3
Congestive heart failure 13.0
Pulmonary disease 33.6
Diabetes 23.8
Hypertension 72.9
End-stage renal disease 6.1
Cancer 17.7
Metastatic cancer 2.7
Dementia 2.3
Liver disease
Mild 1.8
Moderate to severe 0.8
Human immunodeficiency virus 0.1
Previous laparotomy 1.2
Paraplegia 2.4
Distinct drug Rx in year pre-op, No. 8.0 (4.0-12.0
Urgent hospital admissions in year pre-op,
No.
Median 0.0 (0.0-0.0)
Mean 0.41 (0.36-0.4
CI, Confidence interval; RR, relative risk; Rx, prescription.
aMedian and mean values expressed with interquartile ranges.
Fig 2. Survival distribution function with 95% confiden
endovascular aneurysm (EVAR) and open repair proced
axis, days from elective abdominal repair; vertical axis, pstudy examined procedures in patients aged67 years in theMedicare population between 2001 and 2004. Our study,
which showed similar results, included all ages undergoing
elective AAA treatment in a different universal health care
system and classified patients into operative groups by a vali-
dated coding algorithm. We performed a post hoc stratified
analysis by quintile but did not observe any obvious trends in
survival benefit; however, thismay be a result of a limitation in
ominal aortic aneurysm repair and endovascular
Open repair, % RR (95% CI)
P(n 5573) EVAR vs open
72.0 (66.0-77.0)a . . . .0001
80.3 1.07 (1.04-1.10) .0001
32.3 1.52 (1.40-1.64) .0001
9.9 1.40 (1.15-1.68) .0001
28.6 1.48 (1.28-1.69) .0001
6.7 1.93 (1.57-2.35) .0001
21.7 1.55 (1.39-1.72) .0001
18.0 1.32 (1.16-1.51) .0001
60.9 1.20 (1.14-1.25) .0001
3.1 1.95 (1.43-2.64) .0001
12.7 1.40 (1.19-1.64) .0001
1.1 2.43 (1.48-3.95) .0001
1.3 1.77 (1.05-2.95) .03
1.2 1.48 (0.83-2.60) .2
0.3 2.58 (0.98-6.58) .06
0.05 2.09 (0.09-22.3) .99
0.6 1.97 (0.95-4.01) .07
1.2 2.00 (1.19-3.32) .0001
6.0 (1.0-10.0)a . . . .0001
. . . .0001
0.0 (0.0-0.0)a . . . . . .
0.24 (0.22-0.26) . . . . . .
ervals (dashed lines) is shown for all patients undergoing
in Ontario from April 2002 to March 2007 (horizontal
rtion of patients alive).abd
007
0)a
)a
a
7)ce int
uresour sample size.
nosis.
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 3 Jetty et al 581The importance of level 1 evidence from the random-
ized controlled trials cannot be over-emphasized. These
trials showed that EVAR had a similar long-term mortality
but increased reinterventions and costs. Despite this,
EVAR use has continued to increase (Fig 1). The increased
use of EVAR could be due to a perceived limited general-
izability of the randomized trials because of their highly
Table II. Univariate analysis of 30-day mortality and reso
Outcome EVAR Ope
30-day mortality, % 1.8
Median LOS at index admission, d
Hospital 5.0 (3.0-7.0)a 8.0 (
Intensive care unit 1.0 (1.0-3.0)a 3.0 (
Discharge to long-term care,b % 6.9
Long-term outcomes/patient-year
Days in hospitalc 8.5 1
Reinterventionsd 0.07
Outpatient doctor visitse 15.0 1
Imaging studiesf 3.1
Urgent readmissionsg 0.5
Vascular readmissionsh 0.07
CI, Confidence interval; LOS, length of stay; RR, relative risk.
aMedian values expressed with interquartile ranges.
bDischarge to long-term care facility from index admission.
cThe total number of days spent in the hospital, including all readmissions,
dAny open or endovascular procedure on the abdominal aorta (and its m
performed after the index surgery.
eAll visits after the index surgery to any specialist or primary care physician
fInpatient and outpatient abdominal computed tomography scans and ang
surgery.
gAny readmission with the admission code “urgent.”
hAny readmission with the most responsible diagnosis being a vascular diag
Table III. Multivariate analysis of mortality outcomes
for endovascular aneurysm repair (EVAR) and open
abdominal aortic aneurysm repaira
Mortality outcome
Adjusted HR (95% CI)
PEVAR vs open repair
30-day all-cause mortality 0.34 (0.20-0.59) .0001
Overall all-cause mortality 0.95 (0.81-1.05) .61
CI, Confidence interval, HR, hazard ratio.
aEach analysis adjusted for likelihood of receiving each operative type using
a propensity score analysis.
Table IV. Multivariate analysis of resource utilization
during and disposition from index admission
Outcome
Group comparison (95% CI)
PEVAR vs open repair
Length of stay, d 5.75 (4.85 to 16.65) .0001
Length of stay in ICU, d 2.0 (1.00 to 3.05) .0002
Discharge to long-term
care, RR 0.55 (0.41-0.74) .0001
CI, Confidence interval; EVAR, endovascular aneurysm repair; ICU, inten-
sive care unit; RR, relative risk.selected patient population or the perceived improvementin EVAR technology and expertise since the studies were
conducted.
Some other results from our study are notable. First,
although Ontario has seen a steady rise in EVAR use (Fig
1), EVAR was used in only 26% of elective AAA repairs by
the end of the study period. This is small compared with
many American centers, in which almost half of patients
utilization outcomes
air RR or rate ratio (95% CI) EVAR vs open P
0.53 (0.31-0.89) .01
1.0)a . . . .0001
.0)a . . . .0001
0.87 (0.67-1.14) .33
0.81 (0.73-0.90) .0001
1.32 (1.00-1.75) .05
1.21 (1.14-1.30) .0001
6.23 (5.60-6.92) .0001
1.67 (1.45-1.93) .0001
2.22 (1.49-3.32) .0001
e entire follow-up period.
ranches), pelvic, or lower extremity vessels, and abdominal wall repairs,
emergency department or clinic.
hy, and outpatient abdominal magnetic resonance imaging after the index
Table V. Multivariate analysis of resource utilization
after index hospitalization
Outcome/patient-year
Rate ratio (95% CI)
P
EVAR vs open
repair
Reinterventionsa 1.31 (0.98-1.75) .073
Imaging studiesb 5.48 (4.91-6.11) .0001
Outpatient doctor visitsc 1.09 (1.02-1.16) .01
Urgent readmissionsd 1.23 (1.07-1.43) .004
Vascular readmissionse 1.59 (1.04-2.42) .03
Days in hospitalf 0.67 [0.61-0.74] .0001
AAA, Abdominal aortic aneurysm; CI, confidence interval; EVAR, endo-
vascular aneurysm repair.
aAny open or endovascular intervention on the abdominal aorta (and its
major branches), pelvic, or lower extremity vessels, and abdominal wall
repairs, performed after the index surgery.
bInpatient and outpatient abdominal computed tomography scans and
angiography, and outpatient abdominal magnetic resonance imaging, after
the index surgery.
cAll visits after the index surgery to any specialist or primary care physician in
the emergency department or clinic.
dAny readmission with the admission code “urgent.”
eAny readmission with the most responsible diagnosis being a vascular
diagnosis.
fThe total number of days spent in the hospital, including all readmissions,
for the entire follow-up period.urce
n rep
3.4
6.0-1
2.0-5
7.9
0.3
0.05
2.3
0.5
0.3
0.03
for th
ajor b
in the
iograpwith a nonruptured AAA underwent EVAR during the
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implementing EVAR during this period; as well, Ontario
has a single-payer system resulting in less avenues to imple-
ment new technologies compared with the United States.
Although this study likely captured surgeons during the
early and middle portions of the EVAR learning curve,
operative and long-term mortality results are similar to
those previously reported in the randomized trials and
population-based studies.
Second, EVAR is significantly more common in sicker
patients (Table I). This explains why the large increase in
unadjusted long-term mortality seen with EVAR (Fig 2)
disappeared when we adjusted for these factors (Table III).
Third, the adoption of minimally invasive surgical tech-
niques is often accompanied by increased volume of proce-
dures as a result of lower operative thresholds. This did not
seem to be the case for EVAR during this study period in
Ontario. The total number of patients treated for AAAs
remained fairly stable during the study period. This sug-
gests that the same size threshold for open repair was likely
respected for EVAR. In addition, these data suggest that
there has not been any perceivable rise in overall number of
procedures due to previously unoperated-on patients un-
dergoing EVAR.
Although differences between EVAR and open repair
in reintervention rates did not reach statistical difference, a
small trend favored open repair (odds ratio, 1.3). This
difference is much smaller than what was previously re-
ported and could reflect improvements in EVAR tech-
nique, endograft technology, or a higher threshold for
reinterventions for complications after EVAR such as type 2
endoleaks. This could also potentially result in a decrease in
radiologic monitoring in the future.31
Biased results due to patient selection were mini-
mized using propensity score analysis. Patients in each
propensity score stratum were balanced in their comor-
bidities and other factors that influence treatment mo-
dality selection. Although propensity score analysis does
not eliminate bias from unobserved variables, our model
indicates that the covariates used in our propensity
model were very influential in the decision to use EVAR
or open repair. We therefore consider it unlikely that an
Table VI. Short-term and long-term mortality outcomes
Outcomeb
Quintile 1 Quintile
EVAR, 73;
Open, 1219
EVAR, 8
Open, 12
All-cause, mortality, HR 3.48 0.61
P .22 .12
30-day mortality, OR Incalculablec 0.87
P 1.0
EVAR, Endovascular aneurysm repair; HR, hazard ratio; OR, odds ratio
aQuintile 1 has the lowest probability of being assigned EVAR, whereas qu
patients who received EVAR by quintile was Q1  8.2%, Q2  10.0%, Q3
bEVAR vs open repair.
cIncalculable to zero cell in EVAR group.unobserved variable could have significantly affected theresults. The propensity score method was a valid tech-
nique to use in this study because the decision regarding
the treatment modality depends heavily on the patient’s
risk status. However, if EVAR is liberalized to all risk
groups, the decision to proceed with EVAR would de-
pend more on anatomic suitability and less so on patient
comorbidities. Such a trend would make the use of
propensity score analysis based solely on patient comor-
bidities less valid as an adjustment method.
A limitation of our study is the use of administrative
databases and the quality of coding. First, administrative
databases can be susceptible to inaccurate coding. We
minimized this problem in our analysis by developing and
using a coding algorithm that classified patients in the
correct surgical treatment group with 95% accuracy.21
Second, our study did not capture actual operative or
postoperative costs. Instead, we focused on resource utili-
zation to avoid the issue of varying costs between hospitals.
Several studies suggested that in-hospital and follow-up
costs are greater with EVAR than with open repair.32-34
Finally, this study was not able to distinguish between
resource utilization outcomes (such as imaging studies)
that were a result of the initial surgical procedure from
those that were unrelated, potentially leading to an overes-
timation of the number of outcomes. There is no reason,
however, to assume that there was any relative difference
between this discrepancy for open repair and EVAR.
CONCLUSIONS
This population-based study demonstrated that pa-
tients undergoing EVAR have significantly improved short-
term mortality and decreased short- and long-term health
institution occupancy. EVAR did not change long-term
survival, however, and it increased radiologic monitoring.
With rapid and constant changes in EVAR technology,
thresholds for reinterventions, and follow-up imaging re-
quirements, ongoing monitoring of EVAR and open AAA
repair survival and resource utilization outcomes is re-
quired.
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The enhanced version of the International Statistical
Classification of Diseases and Related Health Problems, 10th
Revision (ICD-10-CA), and the Canadian Classification of
Health Interventions (CCI) coding systems were used to
identify patients who underwent open repair vs endovascu-
lar aneurysm repair (EVAR) techniques for nonruptured
abdominal aortic aneurysms (AAAs). This was done using a
validated coding algorithm that yields an overall procedure
assignment accuracy of 97.3% (95% CI, 94.2%-97.6%) for
EVAR and 95.9% (95%CI, 95.9%-98.7%) for open repair at
our institution.20
The ICD-10. The ICD-10 is an international stan-
dard for reporting clinical diagnoses developed by the
World Health Organization. ICD-10-CA, an enhanced
version of ICD-10 developed by the Canadian Institute for
Health Information (CIHI), classifies diseases using an
alpha-numeric code of 3 to 6 characters. Before the imple-
mentation of ICD-10-CA, a variety of medical classification
standards were used in Canada for morbidity purposes.
Two standards were in use at the national level for diagnosis
classification: the International Statistical Classification of
Diseases, Injuries, and Causes of Death, Ninth Revision
(ICD-9) and the ICD-9-Clinical Modification (ICD-9-
CM). This mixture of classification standards existed in
Canada from 1979 and on the CIHI Discharge Abstract
Database from 1987. As of April 1, 2002, this mix of
classifications was replaced with the new, single, national
standards for diagnosis and procedure classification, the
ICD-10-CA and the CCI.
The Canadian Classification of Health Interven-
tions. The CCI is the new national standard for classifying
health care procedures and is the companion classification
system to ICD-10-CA. CCI replaces the Canadian Classi-
fication of Diagnostic, Therapeutic and Surgical Proce-
dures (CCP) and the intervention portion of ICD-9-CM in
Canada. It was implemented in Ontario at the same time as
ICD-10-CA, in April 2002. The CCI classifies a broad
range of interventions, including therapeutic interventions
such as inpatient and day surgeries and diagnostic interven-
tions such as diagnostic imaging, tests, measurements, bi-
opsies, and explorations. It is very precise and has separate
distinct codes for EVAR and open repair of AAAs. Before
this, no distinction was made between the two approaches
in the coding systems. As a result, our study period starts
from 2002.
Coding algorithm
EVAR group
Diagnostic code I71.4 and
Intervention codes 1.KA.80.GQ-NRN or
1.KA.50.GS-BD or
1.KA.50.LA-BD or
1.KE.50.GQ-OA or
1.KE.51.GQ-GE
Open surgical groupa
Diagnostic code I71.4 and
Intervention codes 1.KA.80.LA-XXN orAppendix I, online only. Coding algorithm continued.
1.KA.76.NB-XXN or
1.KA.76.MZ-XXN
aAny patient coded as an open repair but who did not have a general
anesthetic (INATEC1-20 codes 2, 3, 5, 6, 7, 8, 9, 10) will be considered to
have had an EVAR.
Appendix II, online only. Definitions of outcome
measures—reinterventions
Reinterventions per patient-year. Procedures with
certain vascular, endovascular, or interventional radiology Cana-
dian Classification of Health Interventions (CCI) codes in the
Canadian Institute for Health Information Discharge Abstract
Database (CIHI-DAD) with an intervention date beyond the
index surgery date were considered reinterventions. These in-
cluded any open or endovascular procedure on the abdominal
aorta (and its major branches), pelvic, or lower extremity vessels,
and abdominal wall repairs. These were identified in the DAD
using the following CCI code prefixes:
Open or endovascular intervention Code prefix
Aortic interventions 1.KA.^^.^^
Abdominal arteries interventions 1.KE.^^.^^
Pelvic vessels interventions 1.KT.^^.^^
Leg arteries interventions 1.KG.^^.^^
Axillofemoral bypass 1.JM.MI-XXN
Abdominal wall procedures 1.SY.80.^^
The following are examples of reintervention proce-
dures that would be captured using the above codes:
i. Endovascular aortic aneurysm repair
ii. Open repair of abdominal aortic aneurysm
iii. Excision of aortic graft/stent
iv. Balloon angioplasty
v. Stent insertion into aorta or iliac arteries
vi. Embolization of any vessel
vii. Groin exploration
viii. Thrombectomy of vessel
ix. Embolectomy of vessel
x. Ligation of bleeding vessel
xi. Any reoperation on aorta, iliac vessel, or femoral
vessel
xii. Any operation for aortoduodenal fistula
xiii. Any operation for infected aortic graft
xiv. Any operation for occluded aortic graft
xv. Axillofemoral bypass
xvi. Femorofemoral bypass
xvii. Abdominal wall repair
Appendix III, online only. Definitions of variables
(based on the Charlson Comorbidity Index)
1. Age
i. Age at time of the initial surgical procedure. Infor-
mation was obtained from the Registered Persons
Database (RPDB).
2. Sex
i. Gender was determined from information in theRPDB.
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i. Any patient with a diagnostic code for peripheral
vascular disease in the Canadian Institute for
Health Information Discharge Abstract Database
(CIHI DAD), including atherosclerosis of any ves-
sel(s) in the body, excluding cerebral, coronary,
and pulmonary. Also includes patients with previ-
ous aneurysm, dissection, andmesenteric ischemia.
4. Coronary artery disease
i. Any patient with a diagnostic code for coronary
artery disease in the CIHI DAD, including acute
myocardial infarction, or old myocardial infarction
(based on electrocardiogram or other tests).
ii. Any patient previously entered into the Ontario
Myocardial Infarction Database (OMID).
iii. Any patient in the Ontario Drug Benefits (ODB)
database with a previous prescription of nitroglyc-
erine in the year before the index surgery (Appen-
dix IV, online only).
5. Heart failure
i. Anypatientwithadiagnosticcode forheart failure in the
CIHIDAD, including any cardiomyopathy, congestive
heart failure, hypertensive heart disease, or pericarditis.
6. Chronic pulmonary disease
i. Any patient with a diagnostic code for chronic
obstructive pulmonary disease in the CIHI DAD,
including emphysema, chronic bronchitis, asthma,
bronchiectasis, pneumoconiosis, and chronic re-
spiratory conditions due to external agents.
ii. Any patient with a prescription for a bronchodila-
tor, inhaled steroids, or cholinergic agent in the
ODB database during the year before surgery.
7. Diabetes
i. Any patient with a diagnostic code for diabetes
mellitus in the CIHI DAD before the index opera-
tion, including insulin-dependent and noninsulin-
dependent diabetes mellitus, and excluding gesta-
tional diabetes mellitus.
ii. Any patient in the Ontario Diabetes Database.
8. Hypertension
i. Any patient with a prescription for an antihyperten-
sive agent in the ODB database during the year
before surgery, including -blockers, calcium chan-
nel blockers, angiotensin-converting enzyme in-
hibitors, and combination drugs.
9. Previous cancer
i. Any patient with a diagnostic code for cancer in the
CIHI DAD, including malignant neoplasms, ma-
lignant neoplasms of ill defined, secondary, and
unspecified sites, or malignant neoplasms of lym-
phoid, hematopoietic, and related tissue.
ii. in situ neoplasms and benign neoplasms are not
included.
10. Metastatic cancer
i. Any patient with a diagnostic code for metastatic
cancer in the CIHI DAD, including to lymph
nodes or any secondary organ or site.11. Chronic renal failure
i. Any patient with a diagnostic code for chronic
renal failure in the CIHI DAD.
ii. Any patient with billing codes for dialysis in the
OntarioHealth Insurance Plan database during the
year before surgery.
12. Mild liver disease
i. Any patient with a diagnostic code for mild liver
disease in the CIHI DAD, including chronic hep-
atitis, cirrhosis, and alcoholic liver disease.
13. Moderate or severe liver disease
i. Any patient with a diagnostic code for major liver
disease in the CIHI DAD, including chronic he-
patic failure, hepatic venous occlusion, portal hy-
pertension, hepatorenal syndrome, and varices.
14. Dementia
i. Any patient with a diagnostic code for dementia in
the CIHI DAD, including dementia in Alzhei-
mer’s disease, vascular dementia, or dementia asso-
ciated with other diseases.
ii. Any patient with a prescription for cholinesterase
inhibitor in the ODB database during the year
before surgery.
15. Connective tissue disease
i. Any patient with a diagnostic code for a connective
tissue disorder in the CIHI DAD, including rheu-
matoid arthritis, systemic lupus erythematosus, sys-
temic sclerosis, polymyalgia rheumatica, and giant
cell arteritis.
16. Peptic ulcer disease
i. Any patient with a diagnostic code for peptic ulcer
disease in the CIHI DAD, including gastric, duo-
denal, or jejunal ulceration.
17. Paraplegia and hemiplegia
i. Any patient with a diagnostic code for paraplegia or
hemiplegia in the CIHI DAD, including cerebral
palsy or any paralytic syndrome.
18. HIV/AIDS
i. Any patient previously with a diagnostic code for
HIV or AIDS in the CIHI DAD.
ii. Any patient with a prescription for an antiretroviral
drug in the ODB database during the year before
surgery.
19. Previous laparotomy
i. Any patient with a diagnostic code for previous
laparotomy incision in the CIHI DAD.
20. Number of medications
i. The number of different prescriptions for each
patient during the year before surgery was calcu-
lated by using distinct drug identifier numbers in
the ODB database for each patient.
21. Number of urgent admissions in the year before
surgery
i. The number of urgent or emergent admissions to a
hospital during the year before surgery in the CIHI
DAD was calculated for each patient.
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Initial model entered: Endovascular aneurysm repair sex, age*age, peripheral vascular disease (PVD), cerebrovascular
disease, paraplegia, congestive heart failure (CHF), liver, dementia, cancer, HIV, pulmonary disease, heart disease, diabetes
mellitus, kidney, hypertension, laparotomy, drug decile, admissions group, age*heart disease, age*sex, pulmonary*heart
disease, diabetes*heart disease.
Final model useda
Variable LR test Pb Point estimate 95% CIs
1. Age*age 183.8 .001 . . . . . .
2. PVD 268.2 .001 1.62 1.38-1.90
3. Sex (F vs M) 297.9 .001 0.55 0.45-0.68
4. No. of drugs (deciles) 351.6 .0013 0.78-1.86 . . .
5. Pulmonary 362.2 .0066 1.27 1.07-1.51
6. Mets 369.1 .0061 2.00 1.22-3.30
7. CHF 375.5 .0179 1.34 1.05-1.70
8. Hypertension 379.7 .0417 0.80 0.64-0.99
9. Diabetes mellitus 383.5 .0368 1.21 1.01-1.46
10. Paraplegia 387.0 .0545 1.67 0.99-2.83
11. Admissions (3 groups) 392.2 .0633 1.09-1.42 . . .
12. Liver 394.8 .0908 2.23 0.88-5.67
CI, Confidence intervals; F, female; LR, likelihood ratio test; M, male.
aAfter step 12 no other variables met the 0.2 level of significance and therefore were not entered.
bType 3 AOE (analysis of effects).
